Nurse Practitioner · Poughkeepsie, NY
NPI
1790916310
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
45 Reade Pl Fl 2
Poughkeepsie, NY, 12601
Phone (845) 483-6001
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
758 services
Medicare patients, 2024
353
Average age 74
Drug cost, 2024
$2.0M
1,022 prescriptions
Company payments, 2025
$281
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret McCabe was code 99214 (office e&m - established), 405 times for 263 patients. In total Margaret McCabe billed 758 services in 11 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 405 | 263 | $87.25 | $35K |
| 36415 Venipuncture Blood Collection | Office | 206 | 131 | $8.61 | $1,774 |
| 99213 Office E&M - Established | Office | 89 | 64 | $62.06 | $5,524 |
| 99212 Office E&M - Established | Office | 18 | 15 | $42.14 | $758 |
| 99442 Telephone Services | Office | 12 | 12 | $61.87 | $742 |
By year: 2022 $64K for 1,053 services; 2023 $50K for 747 services; 2024 $46K for 758 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 206 | 131 | $8.61 | $1,774 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret McCabe prescribed most often to Medicare patients was Anastrozole, with 167 prescriptions and refills. In total Margaret McCabe wrote 1,022 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 167 | 434 | 59 | $3,432 |
| Letrozole Generic | 151 | 373 | 53 | $2,498 |
| Eliquis Apixaban | 85 | 107 | 16 | $59K |
| Potassium Chloride Generic | 33 | 41 | 17 | $249 |
| Tamoxifen Citrate Generic | 23 | 56 | Under 11 | $423 |
| Xarelto Rivaroxaban | 23 | 37 | Under 11 | $20K |
| Levothyroxine Sodium Generic | 23 | 33 | Under 11 | $386 |
| Valacyclovir Valacyclovir Hcl | 22 | 38 | Under 11 | $837 |
| Xpovio Selinexor | 21 | 21 | Under 11 | $578K |
| Hydroxyurea Generic | 21 | 40 | Under 11 | $774 |
| Oxycodone Hcl Generic | 20 | 20 | Under 11 | $245 |
| Gabapentin Generic | 20 | 26 | Under 11 | $121 |
| Exemestane Generic | 19 | 56 | Under 11 | $2,722 |
| Ibandronate Sodium Generic | 19 | 37 | Under 11 | $745 |
| Morphine Sulfate Er Morphine Sulfate | 18 | 18 | Under 11 | $577 |
Brand drugs: 225 claims; generic drugs: 797 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret McCabe $281 ($281 in general payments such as food, travel and fees) from 3 companies. The largest payer was Merck Sharp & Dohme LLC with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.